The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform Encephalopathies
- 26 September 1996
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (13) , 924-930
- https://doi.org/10.1056/nejm199609263351303
Abstract
There is no practical and reliable premortem test for Creutzfeldt–Jakob disease and the related transmissible spongiform encephalopathies. Two proteins, designated 130 and 131, which have been detected in low concentrations in cerebrospinal fluid from patients with Creutzfeldt–Jakob disease, appear to be sensitive and specific markers for the disease. Attempts to identify these proteins, however, have been unsuccessful. We hypothesized that they may be present in the normal brain.Keywords
This publication has 32 references indexed in Scilit:
- A new variant of Creutzfeldt-Jakob disease in the UKPublished by Elsevier ,1996
- Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob diseaseThe Lancet, 1995
- High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1992
- "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob diseaseThe Lancet, 1992
- Marked increase in cerebrospinal fluid ubiquitin in Creutzfeldt-Jakob diseaseNeuroscience Letters, 1992
- Fatal Familial Insomnia, a Prion Disease with a Mutation at Codon 178 of the Prion Protein GeneNew England Journal of Medicine, 1992
- Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteinsJournal of the Neurological Sciences, 1990
- A new case of Creutzfeldt‐Jakob disease associated with human growth hormone therapy in New ZealandNeurology, 1988
- Elevated Cerebrospinal Fluid Lactic Acid Levels in Creutzfeldt-Jakob DiseaseInternational Journal of Neuroscience, 1988
- Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt–Jakob DiseaseNew England Journal of Medicine, 1986